{"id":"W3159134974","doi":"10.1210/jendso/bvab048.051","title":"Safety and Tolerability of Concomitant Administration of Multiple-Dose AM833 With Semaglutide 2.4 MG for Weight Management","year":2021,"lang":"en","type":"article","venue":"Journal of the Endocrine Society","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Semaglutide; Tolerability; Medicine; Placebo; Cmax; Adverse effect; Clinical endpoint; Internal medicine; Pharmacodynamics; Randomized controlled trial; Pharmacology; Pharmacokinetics; Endocrinology; Type 2 diabetes; Liraglutide; Diabetes mellitus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000273599,0.0001064911,0.0004017978,0.00001720958,0.00004465218,0.000006461069,0.00007158968,0.00001751045,0.00001620662],"category_scores_gemma":[0.00005663755,0.00006187611,0.0003251994,0.0001060863,0.00009504682,0.00004946615,0.00007049923,0.00008811378,8.413828e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007320504,"about_ca_system_score_gemma":0.00008256814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002488058,"about_ca_topic_score_gemma":0.000008833148,"domain_scores_codex":[0.9989731,0.00003482164,0.0004914909,0.0001100605,0.0002629067,0.0001276035],"domain_scores_gemma":[0.9988843,0.0001328192,0.00043877,0.000223997,0.0002638342,0.00005632737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02032942,0.009810422,0.7644244,0.01325774,0.02451161,0.0006071936,0.004216082,0.0005657282,0.04686544,0.01190832,0.03017427,0.07332941],"study_design_scores_gemma":[0.05000592,0.005023562,0.6370906,0.001801713,0.006488971,0.0005806633,0.006699591,0.001819844,0.2201201,0.001103117,0.06888781,0.0003781818],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910892,0.0005323875,0.0009461559,0.005639129,0.0001503893,0.0006578571,0.00002405035,0.000005379433,0.0009554889],"genre_scores_gemma":[0.9814962,0.0004202803,0.01668684,0.0001672339,0.00005711056,0.000005617108,0.000005365683,0.000009360474,0.001152062],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1732546,"threshold_uncertainty_score":0.2523234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01088740040193901,"score_gpt":0.2618362265112082,"score_spread":0.2509488261092692,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}